This study is currently not accepting new patients, but might later
A Study of Sacituzumab Govitecan in Metastatic Solid Tumors (TROPICS-03)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSD
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- currently not accepting new patients, but might later
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Immunomedics, Inc.
- ID
- NCT03964727
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated